Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06978894

Predicting Psychotic Relapse Using Speech-Based Early Detection

Sponsor: Douglas Mental Health University Institute

View on ClinicalTrials.gov

Summary

Psychotic disorders, including schizophrenia and affective psychosis, are severe mental health conditions marked by recurrent episodes that contribute to long-term disability. Relapses, characterized by the re-emergence of psychotic symptoms after remission, are a critical factor in the progression of these disorders, increasing risks such as suicide, cognitive impairment, and unemployment. This study aims to develop a novel, speech-based digital model to predict relapses in individuals with psychosis. Building on previous research into language abnormalities in schizophrenia, the study will employ a longitudinal design across Early Psychosis Intervention (EPI) clinics in Ontario and Quebec to advance relapse prediction

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

OBSERVATIONAL

Enrollment

250

Start Date

2024-05-27

Completion Date

2029-07-01

Last Updated

2025-05-18

Healthy Volunteers

No

Conditions

Locations (3)

Robarts Research Institute

London, Ontario, Canada

Douglas Mental Health University Institute

Montreal, Quebec, Canada

Vitam

Québec, Quebec, Canada